Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tri-isoflavones is a botanical dietary supplement in preclinical development by Natural Pharmacia International (NPI) for the management of postmenopausal symptoms and the prevention of bone loss. The formulation consists of three specific plant-derived isoflavones that function as phytoestrogens. These compounds are designed to act as natural estrogen receptor agonists, mimicking the effects of endogenous estrogen to alleviate symptoms such as hot flashes and to help maintain bone mineral density in postmenopausal women. As a naturally derived product, it is positioned as a potential alternative to traditional hormone replacement therapy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Tri-isoflavones.